SAVID THERAPEUTICS INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SAVID THERAPEUTICS INC..The latest application filed is for "fusion protein of antibody that recognizes cancer cells and mutant streptavidin".

Company Profile

11.10.15

SAVID THERAPEUTICS INC. - Tokyo N/A JP
Savid Therapeutics Inc. - Suginami-ku, Tokyo JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein Grant 11,442,066 - Suzuki , et al. September 13, 2	2022-09-13
Modified biotin, streptavidin mutant, and usage of them Grant 11,286,285 - Sugiyama , et al. March 29, 2	2022-03-29
Fusion Protein Of Antibody That Recognizes Cancer Cells And Mutant Streptavidin App 20220073641 - TANAKA; Toshiya ; et al.	2022-03-10
Conjugate Of Biotin-modified Dimer And Phthalocyanine Dye App 20220016245 - KANAI; Motomu ; et al.	2022-01-20
Modified biotin, streptavidin mutant, and usage of them Grant 11,161,884 - Sugiyama , et al. November 2, 2	2021-11-02
Modified biotin, streptavidin mutant, and usage of them Grant 11,124,549 - Sugiyama , et al. September 21, 2	2021-09-21
Halogenated Biotin-modified Dimer And Use Thereof App 20210214376 - KANAI; Motomu ; et al.	2021-07-15
Use Of Bis-iminobiotin Compound For Drug Delivery Purposes App 20210030882 - SUZUKI; Tsuneji ; et al.	2021-02-04
Antisulfataed Glycosaminoglycan Antibody App 20200283510 - ISHIKAWA; Shumpei ; et al.	2020-09-10
Modified Biotin, Streptavidin Mutant, And Usage Of Them App 20200017558 - SUGIYAMA; Akira ; et al.	2020-01-16
Clearing Agent App 20190382435 - TSUKAGOSHI; Masanobu	2019-12-19
Method For Identifying Drug-discovery Target Protein For Development Of Antibody Drug, And Method For Producing Antibody Against App 20190383821 - SUZUKI; Tsuneji ; et al.	2019-12-19
Modified biotin, mutant streptavidin, and use thereof Grant 9,670,255 - Sugiyama , et al. June 6, 2	2017-06-06
Modified Biotin, Streptavidin Mutant, And Usage Of Them App 20170145063 - SUGIYAMA; Akira ; et al.	2017-05-25
Modified Biotin, Mutant Streptavidin, And Use Thereof App 20160137704 - SUGIYAMA; Akira ; et al.	2016-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.